Back to today’s briefing

Story perspectives

Rising Tariffs Risk Drug Shortages and Patient Care

4/24/2025

34 5

Left

Experts Warn Tariff Impact

Experts caution that rising tariffs on pharmaceuticals amid the U.S.-China trade war could drive up drug prices for American patients. With the U.S. dependent on China for vital ingredients, these tariffs threaten to create shortages, disproportionately impacting low-income communities and jeopardizing patient care and health equity.

Center

Eton Pharmaceuticals Price Hike

Eton Pharmaceuticals has sparked outrage by hiking the price of a rare growth disorder treatment by a staggering 150%, pushing it from $5,882 to $14,705 per vial. This controversial decision comes amid new federal laws mandating rebates for such price increases. Meanwhile, European pharmaceutical leaders are calling on the EU to elevate drug prices to stimulate innovation, highlighting the stark contrast with soaring U.S. costs.

History

Historical Context

Rising tariffs on pharmaceuticals during the U.S.-China trade war echo the 1980s auto tariffs that inflated car prices and sparked public outrage. Both events highlight how protectionist policies threaten access to essential goods, particularly for vulnerable populations, underscoring a recurring theme of economic consequences from trade disputes.

1 of 3

Experts Warn Tariff Impact

Experts caution that rising tariffs on pharmaceuticals amid the U.S.-China trade war could drive up drug prices for American patients. With the U.S. dependent on China for vital ingredients, these tariffs threaten to create shortages, disproportionately impacting low-income communities and jeopardizing patient care and health equity.

1 / 3